within Pharmacolibrary.Drugs.ATC.J;

model J01GB08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1.0,
    Cl             = 0.025,
    adminDuration  = 600,
    adminMass      = 0.08,
    adminCount     = 1,
    Vd             = 0.00022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Sisomicin is an aminoglycoside antibiotic, structurally related to gentamicin and netilmicin. It is mainly used for the treatment of severe infections caused by Gram-negative bacteria, and was historically used for conditions such as sepsis, urinary tract infections, and pneumonia. Its clinical use is rare today due to nephrotoxicity and ototoxicity compared to safer alternatives, and it is not in widespread use or approved in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for adult patients with normal renal function after intravenous administration.</p><h4>References</h4><ol><li><p>Roth, S, et al., &amp; Lange, H (1976). Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection. <i>European journal of clinical pharmacology</i> 10(5) 357–365. DOI:<a href=&quot;https://doi.org/10.1007/BF00565626&quot;>10.1007/BF00565626</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/789084/&quot;>https://pubmed.ncbi.nlm.nih.gov/789084</a></p></li><li><p>Komirenko, AS, et al., &amp; Seroogy, JD (2018). A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function. <i>Antimicrobial agents and chemotherapy</i> 62(12) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.01128-18&quot;>10.1128/AAC.01128-18</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30275092/&quot;>https://pubmed.ncbi.nlm.nih.gov/30275092</a></p></li><li><p>Meyers, BR, et al., &amp; Ribner, B (1976). Pharmacokinetic parameters of sisomicin. <i>Antimicrobial agents and chemotherapy</i> 10(1) 25–27. DOI:<a href=&quot;https://doi.org/10.1128/AAC.10.1.25&quot;>10.1128/AAC.10.1.25</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/984754/&quot;>https://pubmed.ncbi.nlm.nih.gov/984754</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01GB08;
